---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-21-027052"
form_type: "8-K"
ticker: "BFRI"
cik: "0001858685"
company_name: "Biofrontera Inc."
filed_at: "2021-11-03T23:59:59+00:00"
generated_at: "2026-06-28T14:35:45.395609+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Biofrontera completes $18M IPO on Nasdaq; net proceeds $15.4M, board expanded with independent directors

## Summary
- IPO of 3.6M units at $5.00/unit (1 share + 1 warrant) closed Nov 2, 2021; gross proceeds $18M, net ~$15.4M.
- Underwriters exercised full over-allotment for additional 540,000 warrants; warrants have $5.00 exercise price, 5-year term.
- Common stock and warrants trade on Nasdaq Capital Market under symbols BFRI and BFRIW.
- Board changes: Erica Monaco resigned; John Borer, Beth Hoffman, and Loretta Wedge appointed; Hoffman and Wedge independent.
- New directors appointed to audit, nominating, and compensation committees.

## SEC filing metadata
- accession: 0001493152-21-027052
- form_type: 8-K
- ticker: BFRI
- cik: 0001858685
- company_name: Biofrontera Inc.
- filed_at: 2021-11-03T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 5.02, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1858685/000149315221027052/0001493152-21-027052-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1858685/000149315221027052/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-21-027052
- JSON: https://secwatch.observer/filing/0001493152-21-027052.json
- Plain text: https://secwatch.observer/filing/0001493152-21-027052.txt

## Key facts
- Executive change
  John J. Borer was appointed as Director at Biofrontera Inc..
  - Action: appointed
  - Role: Director
  source text: John J. Borer, Beth J. Hoffman, Ph.D, and Loretta M. Wedge, CPA, CCGMA (collectively, the “Directors”) were appointed to the board of directors of the Company
  evidence_url: https://www.sec.gov/Archives/edgar/data/1858685/000149315221027052/0001493152-21-027052-index.htm
- Executive change
  Loretta M. Wedge was appointed as Director at Biofrontera Inc..
  - Action: appointed
  - Role: Director
  source text: John J. Borer, Beth J. Hoffman, Ph.D, and Loretta M. Wedge, CPA, CCGMA (collectively, the “Directors”) were appointed to the board of directors of the Company
  evidence_url: https://www.sec.gov/Archives/edgar/data/1858685/000149315221027052/0001493152-21-027052-index.htm
- Executive change
  Erica Monaco resigned as Director at Biofrontera Inc..
  - Action: resigned
  - Role: Director
  source text: Erica Monaco resigned her position on the board of directors of the Company
  evidence_url: https://www.sec.gov/Archives/edgar/data/1858685/000149315221027052/0001493152-21-027052-index.htm
- Executive change
  Beth J. Hoffman was appointed as Director at Biofrontera Inc..
  - Action: appointed
  - Role: Director
  source text: John J. Borer, Beth J. Hoffman, Ph.D, and Loretta M. Wedge, CPA, CCGMA (collectively, the “Directors”) were appointed to the board of directors of the Company
  evidence_url: https://www.sec.gov/Archives/edgar/data/1858685/000149315221027052/0001493152-21-027052-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.